Xiamen Amoytop Biotech Co.,Ltd.’s Net Profit Rose 58.4% in 2022

Xiamen Amoytop Biotech Co.,Ltd. (厦门特宝生物工程股份有限公司) (688278.SH) reported a net profit of 287 million yuan in 2022, up 58.4% year-on-year.

Meanwhile, the company posted 1.5 billion yuan in revenue, up 34.9% year-on-year.

At the end of the reporting period, it had 1.8 billion yuan in total assets and 361 million yuan in total liabilities, with a liability-to-asset ratio of 20.4%.